ATE533857T1 - Zirkulierende mrna als diagnostische marker für erkankungen die mit einer schwangerschaft zusammenhängen - Google Patents

Zirkulierende mrna als diagnostische marker für erkankungen die mit einer schwangerschaft zusammenhängen

Info

Publication number
ATE533857T1
ATE533857T1 AT04702748T AT04702748T ATE533857T1 AT E533857 T1 ATE533857 T1 AT E533857T1 AT 04702748 T AT04702748 T AT 04702748T AT 04702748 T AT04702748 T AT 04702748T AT E533857 T1 ATE533857 T1 AT E533857T1
Authority
AT
Austria
Prior art keywords
mrna
pregnancy
amount
circulative
mrna species
Prior art date
Application number
AT04702748T
Other languages
English (en)
Inventor
Yuk-Ming Dennis Lo
Kai On Ng
Bo Yin Tsui
Wai Kwun Rossa Chiu
Original Assignee
Univ Hong Kong Chinese
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Hong Kong Chinese filed Critical Univ Hong Kong Chinese
Application granted granted Critical
Publication of ATE533857T1 publication Critical patent/ATE533857T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT04702748T 2003-01-17 2004-01-16 Zirkulierende mrna als diagnostische marker für erkankungen die mit einer schwangerschaft zusammenhängen ATE533857T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44090603P 2003-01-17 2003-01-17
PCT/GB2004/000145 WO2004065629A1 (en) 2003-01-17 2004-01-16 Circulating mrna as diagnostic markers for pregnancy-related disorders

Publications (1)

Publication Number Publication Date
ATE533857T1 true ATE533857T1 (de) 2011-12-15

Family

ID=32771876

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04702748T ATE533857T1 (de) 2003-01-17 2004-01-16 Zirkulierende mrna als diagnostische marker für erkankungen die mit einer schwangerschaft zusammenhängen

Country Status (8)

Country Link
US (3) US7235359B2 (de)
EP (1) EP1583846B1 (de)
JP (1) JP4624977B2 (de)
CN (3) CN101245376A (de)
AT (1) ATE533857T1 (de)
AU (1) AU2004205774B2 (de)
CA (1) CA2513292C (de)
WO (1) WO2004065629A1 (de)

Families Citing this family (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767422B2 (en) * 1998-09-22 2010-08-03 Oncomedx, Inc. Detection of 5T4 RNA in plasma and serum
WO2002018645A2 (en) * 2000-08-28 2002-03-07 Oncomedx, Inc. 5t4 rna in plasma and serum as a marker for neoplastic disease
US20040009518A1 (en) * 2002-05-14 2004-01-15 The Chinese University Of Hong Kong Methods for evaluating a disease condition by nucleic acid detection and fractionation
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
JP2008523816A (ja) * 2004-12-15 2008-07-10 ベス イスラエル ディーコネス メディカル センター 妊娠合併症の診断および処置に有用な核酸およびポリペプチド
AU2006224971B2 (en) * 2005-03-18 2009-07-02 Boston University A method for the detection of chromosomal aneuploidies
EP2161347B1 (de) * 2005-03-18 2016-08-24 The Chinese University Of Hong Kong Marker zur prenatalen Diagnose und zum prenatalen Monitoring
EP2477029A1 (de) * 2005-06-02 2012-07-18 Fluidigm Corporation Auswertung mit mikrofluiden Aufteilungsvorrichtungen
EP1762575A1 (de) * 2005-09-12 2007-03-14 Ganymed Pharmaceuticals AG Identifizierung Tumor-assoziierter Antigene für Diagnoseund Therapie
US7790463B2 (en) * 2006-02-02 2010-09-07 Yale University Methods of determining whether a pregnant woman is at risk of developing preeclampsia
SI3002338T1 (sl) 2006-02-02 2019-11-29 Univ Leland Stanford Junior Neinvaziven genetski pregled zarodka z digitalno analizo
EP1994164A4 (de) * 2006-03-06 2010-07-21 Univ Columbia Spezifische amplifikation fötaler dna-sequenzen aus einer gemischten fötal-maternalen quelle
US7901884B2 (en) 2006-05-03 2011-03-08 The Chinese University Of Hong Kong Markers for prenatal diagnosis and monitoring
EP2029779A4 (de) 2006-06-14 2010-01-20 Living Microsystems Inc Verwendung hoch paralleler snp-genotypisierung zur fötalen diagnose
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
US8372584B2 (en) 2006-06-14 2013-02-12 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
CN101153336B (zh) * 2006-09-27 2011-09-07 香港中文大学 检测dna甲基化程度的方法和试剂盒
US7902345B2 (en) 2006-12-05 2011-03-08 Sequenom, Inc. Detection and quantification of biomolecules using mass spectrometry
EP1970384A1 (de) 2007-03-14 2008-09-17 Ganymed Pharmaceuticals AG Monoklonale Antikörper zur Krebsbehandlung
JP5191041B2 (ja) * 2007-04-05 2013-04-24 エフ．ホフマン−ラ ロシュ アーゲー 急速ワンステップｒｔ−ｐｃｒ
JP5487555B2 (ja) * 2007-04-13 2014-05-07 国立大学法人 長崎大学 胎盤機能の網羅的かつ非侵襲的評価方法および検査用試薬
CN101680884A (zh) * 2007-05-05 2010-03-24 西安大略大学 检测先兆子痫的方法
KR20250002752A (ko) 2007-07-23 2025-01-07 더 차이니즈 유니버시티 오브 홍콩 대규모 병렬 게놈 서열분석을 이용한 태아 염색체 이수성의 진단 방법
US12180549B2 (en) 2007-07-23 2024-12-31 The Chinese University Of Hong Kong Diagnosing fetal chromosomal aneuploidy using genomic sequencing
EP2195452B1 (de) 2007-08-29 2012-03-14 Sequenom, Inc. Verfahren und zusammensetzungen für die universelle grössenspezifische polymerasekettenreaktion
KR20180090396A (ko) 2008-01-18 2018-08-10 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 체액 내에서 질병 또는 병태의 시그너쳐의 검출 방법
US8709726B2 (en) 2008-03-11 2014-04-29 Sequenom, Inc. Nucleic acid-based tests for prenatal gender determination
WO2009120413A2 (en) * 2008-03-27 2009-10-01 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Preventing or reducing risk of miscarriages
US8476013B2 (en) 2008-09-16 2013-07-02 Sequenom, Inc. Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
EP2166021A1 (de) * 2008-09-16 2010-03-24 Ganymed Pharmaceuticals AG Monoklonale Antikörper zur Krebsbehandlung
US8962247B2 (en) 2008-09-16 2015-02-24 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
SMT201700149T1 (it) 2008-09-20 2017-05-08 Univ Leland Stanford Junior Diagnosi non invasiva di aneuploidia fetale mediante sequenziamento
WO2010062377A2 (en) * 2008-10-31 2010-06-03 Yale University Methods and compositions for the detection and treatment of preeclampsia
GB0820999D0 (en) 2008-11-17 2008-12-24 Menon Johansson Anatole S Pregnancy testing
EP2199956A1 (de) * 2008-12-18 2010-06-23 Siemens Aktiengesellschaft Verfahren und System zum Verwalten von Ergebnissen eines Analyseverfahrens an Gegenständen, die entlang einer technischen Verfahrenslinie gehandhabt werden
US8404444B2 (en) * 2009-02-25 2013-03-26 Diacarta Llc Method for predicting the level of damage to cells by measuring free circulating Alu nucleic acid
CN101643785B (zh) * 2009-06-18 2011-12-21 中国人民解放军第二军医大学 用于妊娠高血压综合症检测的hsa-mir-210试剂盒及检测方法
WO2010150259A1 (en) * 2009-06-24 2010-12-29 Fund For Medical Research Development Of Infrastructure And Health Services -Rambam Medical Center Methods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders
CA2779750C (en) 2009-11-06 2019-03-19 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive diagnosis of graft rejection in organ transplant patients
US9926593B2 (en) 2009-12-22 2018-03-27 Sequenom, Inc. Processes and kits for identifying aneuploidy
US20120010085A1 (en) 2010-01-19 2012-01-12 Rava Richard P Methods for determining fraction of fetal nucleic acids in maternal samples
CA2786564A1 (en) 2010-01-19 2011-07-28 Verinata Health, Inc. Identification of polymorphic sequences in mixtures of genomic dna by whole genome sequencing
AU2010343278B2 (en) 2010-01-19 2015-05-21 Verinata Health, Inc. Simultaneous determination of aneuploidy and fetal fraction
US20110312503A1 (en) 2010-01-23 2011-12-22 Artemis Health, Inc. Methods of fetal abnormality detection
EP2371864A1 (de) 2010-03-23 2011-10-05 Ganymed Pharmaceuticals AG Monoklonale Antikörper zur Krebsbehandlung
KR20130123357A (ko) * 2010-06-07 2013-11-12 오스나트 에슈어-파비안 저산소증과 관련된 질환의 진단방법 및 키트
JP5755326B2 (ja) 2010-06-11 2015-07-29 日立化成株式会社 腎機能の特徴を決定する方法
WO2011156734A2 (en) * 2010-06-11 2011-12-15 Hitachi Chemical Co., Ltd. Method of characterizing vascular diseases
US20130177901A1 (en) * 2010-06-18 2013-07-11 Cezanne S.A.S. Markers for the prognosis and risk assessment of pregnancy-induced hypertension and preeclampsia
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
AU2011280944A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting diseases or conditions using phagocytic cells
AU2011280936A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
MX382244B (es) 2010-07-23 2025-03-13 Harvard College Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales
GB201013151D0 (en) * 2010-08-04 2010-09-22 Isis Innovation Diagnostic method
US10533223B2 (en) 2010-08-06 2020-01-14 Ariosa Diagnostics, Inc. Detection of target nucleic acids using hybridization
US8700338B2 (en) 2011-01-25 2014-04-15 Ariosa Diagnosis, Inc. Risk calculation for evaluation of fetal aneuploidy
US20120034603A1 (en) * 2010-08-06 2012-02-09 Tandem Diagnostics, Inc. Ligation-based detection of genetic variants
US11031095B2 (en) 2010-08-06 2021-06-08 Ariosa Diagnostics, Inc. Assay systems for determination of fetal copy number variation
US11203786B2 (en) 2010-08-06 2021-12-21 Ariosa Diagnostics, Inc. Detection of target nucleic acids using hybridization
US10167508B2 (en) 2010-08-06 2019-01-01 Ariosa Diagnostics, Inc. Detection of genetic abnormalities
US20130261003A1 (en) 2010-08-06 2013-10-03 Ariosa Diagnostics, In. Ligation-based detection of genetic variants
US20140342940A1 (en) 2011-01-25 2014-11-20 Ariosa Diagnostics, Inc. Detection of Target Nucleic Acids using Hybridization
US20130040375A1 (en) 2011-08-08 2013-02-14 Tandem Diagnotics, Inc. Assay systems for genetic analysis
JP5782704B2 (ja) * 2010-11-11 2015-09-24 東ソー株式会社 ＧＡＰＤＨｍＲＮＡの測定方法
US9994897B2 (en) 2013-03-08 2018-06-12 Ariosa Diagnostics, Inc. Non-invasive fetal sex determination
US10131947B2 (en) 2011-01-25 2018-11-20 Ariosa Diagnostics, Inc. Noninvasive detection of fetal aneuploidy in egg donor pregnancies
US11270781B2 (en) 2011-01-25 2022-03-08 Ariosa Diagnostics, Inc. Statistical analysis for non-invasive sex chromosome aneuploidy determination
US8756020B2 (en) 2011-01-25 2014-06-17 Ariosa Diagnostics, Inc. Enhanced risk probabilities using biomolecule estimations
CA2834218C (en) 2011-04-29 2021-02-16 Sequenom, Inc. Quantification of a minority nucleic acid species using inhibitory oligonucleotides
EP2717989B1 (de) 2011-06-10 2018-05-30 Hitachi Chemical Co., Ltd. Vesikelaufnahmevorrichtungen und verwendungsverfahren dafür
US8712697B2 (en) 2011-09-07 2014-04-29 Ariosa Diagnostics, Inc. Determination of copy number variations using binomial probability calculations
US20160289762A1 (en) 2012-01-27 2016-10-06 The Board Of Trustees Of The Leland Stanford Junior University Methods for profiliing and quantitating cell-free rna
EP3584327A1 (de) 2012-01-27 2019-12-25 The Board of Trustees of the Leland Stanford Junior University Verfahren zur profilierung und quantifizierung zellfreier rna
EP2820129A1 (de) 2012-03-02 2015-01-07 Sequenom, Inc. Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
US20130237442A1 (en) * 2012-03-07 2013-09-12 University Of Miami Methods and Compositions for Diagnosis of Non-Viable Early Pregnancy
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
US10504613B2 (en) 2012-12-20 2019-12-10 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
JP2015519900A (ja) 2012-05-21 2015-07-16 フリューダイム・コーポレイション 粒子集団の単粒子解析方法及び単粒子単離方法
US10289800B2 (en) 2012-05-21 2019-05-14 Ariosa Diagnostics, Inc. Processes for calculating phased fetal genomic sequences
WO2014011928A1 (en) 2012-07-13 2014-01-16 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
CN104583421A (zh) 2012-07-19 2015-04-29 阿瑞奥萨诊断公司 遗传变体的基于多重的顺序连接的检测
KR101595439B1 (ko) * 2012-12-26 2016-02-19 웰스바이오 주식회사 산모 혈장의 mRNA 발현 차이를 이용한 태아의 염색체 이상 질환의 선별방법
MX391736B (es) * 2013-02-28 2025-03-21 Univ Hong Kong Chinese Analisis del transcriptoma de plasma materno mediante secuenciacion de arn en paralelo a gran escala
GB201318465D0 (en) 2013-10-18 2013-12-04 Oxford Nanopore Tech Ltd Method
EP2965086A4 (de) 2013-03-09 2017-02-08 Harry Stylli Verfahren zum nachweis von prostatakrebs
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
EP2971100A1 (de) 2013-03-13 2016-01-20 Sequenom, Inc. Primer zur analyse der dna-methylierung
CA2907120C (en) * 2013-03-15 2023-10-17 Sera Prognostics, Inc. Biomarkers and methods for predicting preterm birth
WO2014144822A2 (en) 2013-03-15 2014-09-18 Immumetrix, Inc. Methods and compositions for tagging and analyzing samples
JP6297676B2 (ja) 2013-05-06 2018-03-20 日立化成株式会社 標的分子を捕捉するためのデバイス及び方法
WO2015010442A1 (en) * 2013-07-24 2015-01-29 The Chinese University Of Hong Kong Biomarkers for premature birth
WO2015042708A1 (en) 2013-09-25 2015-04-02 Bio-Id Diagnostic Inc. Methods for detecting nucleic acid fragments
EP3736344A1 (de) 2014-03-13 2020-11-11 Sequenom, Inc. Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
WO2016040843A1 (en) 2014-09-11 2016-03-17 Harry Stylli Methods of detecting prostate cancer
KR102457147B1 (ko) 2014-10-17 2022-10-19 옥스포드 나노포어 테크놀로지즈 피엘씨 나노 세공 rna 특징 규명을 위한 방법
US10266895B2 (en) 2014-11-05 2019-04-23 Hitachi Chemical Company Ltd. Exosomes and microvesicles in intestinal luminal fluids and stool and use of same for the assessment of inflammatory bowel disease
US10370719B2 (en) 2014-11-12 2019-08-06 Hitachi Chemical Co., Ltd. Method and device for diagnosing organ injury
CN104593494B (zh) * 2015-01-12 2016-06-08 华中农业大学 猪初生重性状相关plac1基因分子标记的克隆及应用
US10364467B2 (en) 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
US11028443B2 (en) 2015-08-31 2021-06-08 Showa Denko Materials Co., Ltd. Molecular methods for assessing urothelial disease
CN105200150B (zh) * 2015-10-29 2019-03-01 北京泱深生物信息技术有限公司 作为骨关节炎诊治靶标的plac1基因
CN109983137A (zh) * 2016-08-05 2019-07-05 赛拉预测公司 用于预测暴露于孕激素的怀孕女性的早产的生物标志物
WO2019191297A1 (en) * 2018-03-28 2019-10-03 Certara Usa, Inc. Methods and apparatus for quantifying protein abundance in tissues via cell free ribonucleic acids in liquid biopsy
KR102605749B1 (ko) * 2018-05-25 2023-11-23 일루미나, 인코포레이티드 자간전증에 특이적인 순환 rna 시그니처
GB201812192D0 (en) 2018-07-26 2018-09-12 Ttp Plc Variable temperature reactor, heater and control circuit for the same
GB2612911B (en) 2019-02-14 2023-11-22 Mirvie Inc Methods and systems for determining a pregnancy-related state of a subject
EP4035167A1 (de) * 2019-09-25 2022-08-03 Certara USA, Inc. Verfahren und vorrichtung zum erzeugen eines virtuellen modells der xenobiotischen exposition unter verwendung der transfizierten analyse von flüssigen biopsieproben
CN110846400A (zh) * 2019-10-30 2020-02-28 吉林大学 人外周血循环FST mRNA检测试剂盒及其用途
EP4010495A1 (de) * 2019-11-22 2022-06-15 Illumina, Inc. Für präeklampsie spezifische zirkulierende rna-signaturen
CN110951863B (zh) * 2019-12-26 2023-06-02 广州医科大学附属第三医院（广州重症孕产妇救治中心、广州柔济医院） 胎盘植入性疾病标志物
CN110938687B (zh) * 2019-12-26 2023-06-27 广州医科大学附属第三医院（广州重症孕产妇救治中心、广州柔济医院） 胎盘植入性疾病标志物
KR102677892B1 (ko) * 2021-01-14 2024-06-24 연세대학교 산학협력단 자간전증 또는 자간증의 예방 또는 치료용 조성물
CN115786537A (zh) * 2022-11-11 2023-03-14 西昌学院 一种用于绵羊妊娠期免疫力诊断的mRNA生物标志物及其应用
WO2025011401A1 (en) * 2023-07-12 2025-01-16 The Chinese University Of Hong Kong Circulating rna markers for diagnostic use
WO2025055728A1 (en) * 2023-09-12 2025-03-20 The Chinese University Of Hong Kong Circulating markers for parturition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075212A (en) 1989-03-27 1991-12-24 University Of Patents, Inc. Methods of detecting picornaviruses in biological fluids and tissues
US5629147A (en) * 1992-07-17 1997-05-13 Aprogenex, Inc. Enriching and identifying fetal cells in maternal blood for in situ hybridization
US5750339A (en) * 1994-11-30 1998-05-12 Thomas Jefferson University Methods for identifying fetal cells
FR2745638A1 (fr) * 1996-03-04 1997-09-05 Roussy Inst Gustave Procede pour la detection de la transformation maligne de cellules humaines
WO1998026095A1 (en) * 1996-12-10 1998-06-18 Genetrace Systems Inc. Releasable nonvolatile mass-label molecules
GB9704444D0 (en) 1997-03-04 1997-04-23 Isis Innovation Non-invasive prenatal diagnosis
WO2002004678A2 (en) * 2000-07-07 2002-01-17 Genetics Institute, Llc. Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders
US6664056B2 (en) 2000-10-17 2003-12-16 The Chinese University Of Hong Kong Non-invasive prenatal monitoring
JP4216184B2 (ja) * 2001-06-19 2009-01-28 アイダホ リサーチ ファウンデーション 妊娠状態の決定方法
DE60219645T2 (de) * 2001-09-19 2007-08-09 Takeda Pharmaceutical Co. Ltd. Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
US20040009518A1 (en) * 2002-05-14 2004-01-15 The Chinese University Of Hong Kong Methods for evaluating a disease condition by nucleic acid detection and fractionation

Also Published As

Publication number Publication date
JP2006515517A (ja) 2006-06-01
CN101260429A (zh) 2008-09-10
HK1083227A1 (zh) 2006-06-30
CN1723289A (zh) 2006-01-18
CN100379882C (zh) 2008-04-09
JP4624977B2 (ja) 2011-02-02
WO2004065629A1 (en) 2004-08-05
EP1583846A1 (de) 2005-10-12
US20090162842A1 (en) 2009-06-25
US20080153090A1 (en) 2008-06-26
CN101260429B (zh) 2011-03-30
CA2513292C (en) 2016-04-05
EP1583846B1 (de) 2011-11-16
CA2513292A1 (en) 2004-08-05
US7829285B2 (en) 2010-11-09
AU2004205774A1 (en) 2004-08-05
HK1122338A1 (en) 2009-05-15
US7235359B2 (en) 2007-06-26
US20040203037A1 (en) 2004-10-14
CN101245376A (zh) 2008-08-20
AU2004205774B2 (en) 2006-12-14

Similar Documents

Publication Publication Date Title
ATE533857T1 (de) Zirkulierende mrna als diagnostische marker für erkankungen die mit einer schwangerschaft zusammenhängen
Benn Advances in prenatal screening for Down syndrome: I. General principles and second trimester testing
Spencer Screening for trisomy 21 in twin pregnancies in the first trimester using free β‐hCG and PAPP‐A, combined with fetal nuchal translucency thickness
de Melo et al. Applied use of interferon-tau stimulated genes expression in polymorphonuclear cells to detect pregnancy compared to other early predictors in beef cattle
Kindahl et al. Endocrine changes in late bovine pregnancy with special emphasis on fetal well-being
Goetzinger et al. The efficiency of first-trimester serum analytes and maternal characteristics in predicting fetal growth disorders
Metzenbauer et al. First‐trimester placental volume as a marker for chromosomal anomalies: preliminary results from an unselected population
TW200643175A (en) Markers for prenatal diagnosis and monitoring
Spencer et al. The influence of fetal sex in screening for trisomy 21 by fetal nuchal translucency, maternal serum free β‐hCG and PAPP‐A at 10–14 weeks of gestation
Farag et al. Prediction of preeclampsia: can it be achieved?
Ay et al. Screening for pre‐eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha‐fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy
Simões et al. Assessment of luteal function by ultrasonographic appearance and measurement of corpora lutea in goats
Comstock et al. Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening?
DE05739600T1 (de) Adam12, ein neuer marker für abnormale zellfunktion
CA2576646A1 (en) System and method for assessing fetal abnormality based on landmarks
Gupta et al. Adverse pregnancy outcome in patients with low pregnancy‐associated plasma protein‐A: The I ndian E xperience
Svirsky et al. First‐and second‐trimester maternal serum markers of pre‐eclampsia in twin pregnancy
WO2005037059A3 (en) Multi-marker screening protocol for fetal abnormalities
Engels et al. First‐trimester serum marker distribution in singleton pregnancies conceived with assisted reproduction
Christiansen et al. Human placental lactogen is a first‐trimester maternal serum marker of Down syndrome
Palka et al. Non-invasive prenatal screening: A 20-year experience in Italy
Boutin et al. First trimester screening for fetal aneuploidies using placental growth factor: The great obstetrical syndrome (GOS) study
Lam et al. The effect of fetal gender on nuchal translucency at 10–14 weeks of gestation
Christiansen et al. Inhibin A is a maternal serum marker for Down's syndrome early in the first trimester
Cain et al. Biochemical pregnancy diagnosis